Polymyalgia rheumatica and Muscle atrophy

---

Gender of people who have Polymyalgia Rheumatica and experienced Muscle Atrophy *:

• female: 36 %
• male: 64 %

Age of people who have Polymyalgia Rheumatica and experienced Muscle Atrophy *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 0.0 %
• 40-49: 8.33 %
• 50-59: 0.0 %
• 60+: 91.67 %

Common co-existing conditions for these people *:

1. Nuclear Magnetic Resonance Imaging Brain: 3 people, 11.54%
2. Depression: 3 people, 11.54%
3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 3 people, 11.54%
4. Anaemia (lack of blood): 3 people, 11.54%
5. Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 1 person, 3.85%
6. Osteoporosis (bones weak and more likely to break): 1 person, 3.85%
7. High Blood Cholesterol: 1 person, 3.85%
8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.85%
9. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 3.85%

Common drugs taken by these people *:

1. Pantoprazole: 11 people, 42.31%
2. Prednisone: 6 people, 23.08%
3. Wellbutrin Xl: 3 people, 11.54%
4. Magnevist: 3 people, 11.54%
5. Levaquin: 3 people, 11.54%
6. Lasix: 3 people, 11.54%
7. Hectorol: 3 people, 11.54%
8. Fosamax: 3 people, 11.54%
9. Flomax: 3 people, 11.54%
10. Ferrlecit: 3 people, 11.54%

Common symptoms for these people *:

1. Mobility Decreased (ability to move is reduced): 13 people, 50.00%
2. Weakness: 11 people, 42.31%
3. Tendon Rupture (tear of tendon): 10 people, 38.46%
4. Arthropathy: 10 people, 38.46%
5. Vitamin B1 Deficiency: 10 people, 38.46%
6. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 10 people, 38.46%
7. Rashes (redness): 8 people, 30.77%
8. Joint Pain: 8 people, 30.77%
9. Dry Skin: 7 people, 26.92%
10. Hair Loss: 7 people, 26.92%

Do you take medications and have Muscle atrophy?

- Check whether Muscle atrophy is associated with a drug or a condition